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 1 
Abstract 2 
Sab is a mitochondrial scaffold protein involved in signaling associated with mitochondrial 3 
dysfunction and apoptosis; furthermore, Sab is a crucial signaling platform for neurodegenerative 4 
disease. Inhibition of Sab-mediated signaling is effective in models of Parkinson’s disease and 5 
cerebral ischemia. To determine how this signaling nexus could have a significant effect on 6 
disease, we examined the regional abundance of Sab in the brain and sub-neuronal distribution, 7 
and we monitored the effect of Sab-mediated signaling on neuronal activity. We found that Sab 8 
is widely expressed the adult mouse brain with increased abundance in hippocampus, ventral 9 
midbrain, and cerebellum. Sab found in purified synaptosomes and in cultures of primary 10 
hippocampal neurons. Microscopy of mouse hippocampal sections confirmed the mitochondrial 11 
localization of Sab in the soma, dendrites, and axons. Given the localization and sub-neuronal 12 
distribution of Sab, we postulated that Sab-mediated signaling could affect neuronal function, so 13 
we measured the impact of inhibiting Sab-mediated events on the spontaneous activity in 14 
cultured hippocampal neurons. Treatment with a Sab-inhibitory peptide (Tat-SabKIM1), but not a 15 
scrambled control peptide, decreased the firing frequency and spike amplitudes. Our results 16 
demonstrate that brain-specific Sab-mediated signaling plays a role in neuronal activity through 17 
the manipulation of mitochondrial physiology by interacting kinases.18 
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1. Introduction 2 
Mitogen-activated protein kinases (MAPKs) are emerging as critical regulators of 3 
neurological function and disease. The c-Jun N-terminal kinase (JNK) is a serine/threonine 4 
MAPK that is highly expressed and very active in the brain (Brecht et al., 2005; Carboni et al., 5 
1998; Hu et al., 1997; Lee et al., 1999; Lundby et al., 2012) . In fact, JNK isoforms are 6 
extensively linked to neuronal development, function, and disease (Coffey, 2014). This diversity 7 
of function can be attributed to the fact that there are three (3) JNK isoforms in the brain (JNK1, 8 
JNK2, and JNK3), which can be further processed into ten (10) distinct variants (Gupta et al., 9 
1996). The isoforms specifically vary in their tissue and subcellular distributions as well. The 10 
JNK1 isoform accounts for most of the JNK activity in the cortex and cerebellum (Tararuk et al., 11 
2006); meanwhile, JNK3 activity dominates the hippocampus and striatum (Brecht et al., 2005). 12 
In neurons, JNK1 is found predominantly in the cytosol, while JNK3 is largely nuclear; JNK2, 13 
which exhibits the lowest expression in the brain, is distributed between the nucleus and cytosol 14 
(Lee et al., 1999). However, subcellular isoform distribution can vary within specific regions of 15 
the brain depending on the relative abundance of specific JNK isoform expression in each area. 16 
In the adult brain, JNK signaling affects macromolecular transport and synaptic 17 
plasticity. JNK interacts with vesicular structures and binds to microtubule-associated proteins in 18 
the brain (Bjorkblom et al., 2005; Cavalli et al., 2005; Coffey et al., 2000; Feltrin et al., 2012; 19 
Tararuk et al., 2006). Collectively, these studies indicate that JNK signaling plays a role in 20 
vesicle trafficking and deployment during neurotransmission. Furthermore, JNK1-deficient mice 21 
have diminished long-term depression, while JNK2-null mice have reduced late phase long-term 22 
potentiation (Chen et al., 2005; Li et al., 2007). Additionally, JNK1-deficient mice or mice 23 
treated with JNK-selective inhibitors have decreased basal synaptic transmission (Li et al., 2007; 24 
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Yang et al., 2011). These studies demonstrate an importance for JNK signaling in 1 
neurotransmission.  2 
Efficient neurotransmission in the adult brain requires proper levels of adenosine 3 
triphosphate (ATP) and its generation relies on healthy mitochondria. Indeed, perturbations in 4 
mitochondrial function are postulated to precede the onset of cognitive decline and 5 
neurodegenerative disease (Knott et al., 2008; Lin and Beal, 2006). Consequently, molecular 6 
mechanisms regulating mitochondrial physiology have been shown to play crucial roles in 7 
neurotransmission as well as neurological disease (Ivannikov et al., 2013; Small et al., 2011). 8 
While the impact of nuclear and cytosolic JNK activities are documented in the brain, less is 9 
known regarding mitochondrial JNK activity in the brain under physiological conditions (Coffey, 10 
2014). is Sab (SH3 binding protein 5 or SH3BP5) is a scaffold protein present at mitochondria 11 
that facilitates MAPK signaling on the organelle (Chambers et al., 2011a; Wiltshire et al., 2004). 12 
This subcellular location favors the interaction of Sab with cytoplasmic proteins involved in 13 
different signal transduction pathways, facilitating the communication between mitochondria and 14 
the rest of the cell. Specifically, the C-terminal portion of Sab contains two kinase interaction 15 
motifs (KIMs) possessing consensus binding sites for MAPKs (Wiltshire et al., 2002). Indeed, 16 
Sab has interacts with the c-Jun N-terminal kinase (JNK) in response to distinct cellular stimuli, 17 
included neurotoxic chemicals (Aoki et al., 2002; Chambers et al., 2013; Win et al., 2011; Win et 18 
al., 2014).  19 
There is little information regarding the physiological role of mitochondrial JNK 20 
signaling in the adult brain, as most of the studies have focused on the stress responsiveness and 21 
disease-specific contexts of mitochondrial JNK. In response to neurological stress, JNK 22 
translocates to mitochondria and phosphorylates Bcl-2 family proteins; specifically, Bcl-2 like 23 
protein 11 (Bim) and the BH-3 only protein hara-kiri (Hrk) are phosphorylated by JNK during 24 
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serum or nerve growth factor withdrawal as well as during ischemia (Harris and Johnson, 2001; 1 
Lei and Davis, 2003; Putcha et al., 2001; Putcha et al., 2003). We have demonstrated that 2 
mitochondrial JNK signaling can be selectively inhibited by specifically targeting the JNK-Sab 3 
interaction. Using a small, cell-permeable peptide (Tat-SabKIM1) to emulate the JNK binding site 4 
on Sab, we blocked mitochondrial JNK signaling and prevented stress-induced apoptosis without 5 
disrupting nuclear JNK activity (Chambers et al., 2011a). We used this approach to demonstrate 6 
that mitochondrial JNK signaling was a prominent event in the induction of dopaminergic 7 
neurodegeneration in adult rats exposed to 6-hydroxydopamine (Chambers et al., 2013). 8 
Collectively, these studies demonstrate that mitochondrial JNK signaling occurs in the brain. 9 
Given the contributions of JNK to neurological function, our current study was designed 10 
to define the locations of mitochondrial JNK signaling in the adult brain in order to better 11 
understand how this signaling nexus contributes to physiological processes in the brain. We 12 
examined the abundance of Sab in different regions of the brain, its sub-neuronal localization 13 
and a putative role for Sab-mediated signaling in neuronal activity. Sab was found to be 14 
constitutively expressed throughout the adult mouse brain. Further, Sab was expressed in 15 
primary rat hippocampal cultures, cultured astrocytes, and synaptosomes isolated from adult 16 
mice. Sab was found to be largely mitochondrial in axons, dendrites, and soma of hippocampal 17 
neurons. Inhibition of Sab-mediated signaling with the Tat-SabKIM1 peptide impaired basal 18 
activity as indicated by decreased firing frequency and amplitude of spikes in cultured 19 
hippocampal neurons. Taken together, our studies demonstrate that Sab-mediated signaling is 20 
involved in normal neurological processes and the physiological role of JNK in the CNS may 21 
extend to the regulation mitochondrial biology. 22 
 23 
 24 
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2. Results 1 
2.1 Sab is expressed throughout the adult brain. To determine the potential distribution of 2 
mitochondrial JNK (or MAPK) signaling in the brain, we examined the Sab mRNA levels in 49 3 
areas of the adult mouse brain (Figure 1A). Sab expression was widespread in the brain with 4 
particularly high levels in the hippocampus (CA1, CA2/CA3 and dentate gyrus), ventral 5 
midbrain (substantia nigra and ventral tegumental area) and cerebellum (vermis and lobe) 6 
(Figure 1A). We next dissected the brains of adult mice, and acquired proteins to examine the 7 
relative levels of Sab in distinct areas. Sab was detected in the olfactory bulb, frontal cortex, 8 
striatum, hippocampus, ventral midbrain, cerebellum, and brain stem (Figure 1B). In agreement 9 
with the RT-PCR data, Sab protein levels were abundant in the hippocampus, ventral midbrain, 10 
and cerebellum (Figure 1B). Analysis across six adult mice was conducted and plotted for each 11 
region in Figure 1C. 12 
2.2 Sab is expressed in neurons, at synapses, and in astrocytes. Given the brain distribution of 13 
Sab and the previously defined roles for JNK in neuronal function, we examined whether Sab 14 
was expressed in neurons, specifically at synapses. Cytosolic JNK activity is described as high in 15 
the hippocampus; therefore, we cultured hippocampal neurons (with less than 5% of glial cells) 16 
and assessed Sab expression by western blot analysis. Sab was found in cultured neurons (Figure 17 
2A).  Since JNK has been implicated in synaptic transmission, we purified synaptosomes from 18 
adult rat brains. In Figure 2B, four (4) individual synaptosomal preparations show significant 19 
levels of Sab. Finally, to evaluate if Sab was expressed in other cells within the brain, we assayed 20 
human fetal astrocytes for Sab expression, and as demonstrated in Figure 2C, Sab was expressed 21 
in astrocytes.  22 
2.3 Hippocampal Sab is found in axons, dendrites, and synapses. Because cytosolic JNK activity 23 
is elevated in the hippocampal neurons and Sab expression is particularly abundant in the 24 
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hippocampus, we assessed the subcellular distribution of Sab using immunofluorescence and 1 
confocal microscopy in the CA1 hippocampal subfield. Sab presented the prototypic pattern of a 2 
mitochondrial protein, characterized by small intracellular puncta that were particularly apparent 3 
in the cell body of CA1 neurons and the major dendritic profiles of the stratum radiatum (Figure 4 
3A). To confirm the mitochondrial localization of Sab, we performed post-embedding electron 5 
microscopy and analyzed the distribution of gold particles in neuronal profiles of the adult mouse 6 
hippocampus. As shown in Figure 3, Sab labeling was selectively localized in mitochondria and 7 
was generally not associated with other cell organelles. Sab-positive mitochondria were observed 8 
in the different sub-neuronal compartments, i.e. cell bodies (Figure. 3B), dendrites (Figure 3C) 9 
and axon terminals (Figure 3D). Quantification of gold particle density in   these compartments 10 
revealed a significant enrichment of Sab labeling in mitochondria compared with the surrounding 11 
cytoplasm (Table 1). Sab can also be detected in synapses of axonal terminals as illustrated in 12 
Figure 3D. 13 
2.4 Inhibition of Sab-mediated signaling impairs spontaneous hippocampal neuron activity. To 14 
gain insight into the physiological role of Sab, we measured the spontaneous firing of cultured 15 
hippocampal neurons in high potassium using whole-cell patch clamping. Neurons were treated 16 
with either PBS, 5M Tat-Scrambled peptide or 5M Tat-SabKIM1 (to inhibit Sab-mediated 17 
signaling) for 15 minutes prior to recording (Figure 4A). Untreated neurons or neurons treated 18 
with the Tat-Scramble peptide had similar spike rates and amplitudes (Figure 4A-C). Cultured 19 
hippocampal neurons treated with the Tat-SabKIM1 peptide had a decreased firing frequency and 20 
spike amplitude, compared to untreated or scramble peptide-treated neurons (Figure 4B & 4C). 21 
These results collectively demonstrate that Sab is strongly expressed in neuronal mitochondria 22 
and that Sab-mediated signaling affects neuronal activity.  23 
 24 
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3. Discussion 1 
MAPKs are crucial components of neurological and cognitive functions, and elevated 2 
MAPK signaling is a common feature in neurological disease (Kim and Choi, 2010). 3 
Furthermore, mitochondrial MAPK signaling has emerged as a critical regulatory event for 4 
cellular and organelle physiology (Horbinski and Chu, 2005). In the current study, we examined 5 
the distribution of a MAPK mitochondrial scaffold protein, Sab and its contribution to neuronal 6 
function. Sab has been extensively linked to mitochondrial JNK signaling, which has been 7 
shown to induce mitochondrial dysfunction and cell death (Chambers et al., 2011a; Chambers 8 
and LoGrasso, 2011). Our examination of Sab expression in the brain revealed an enrichment of 9 
Sab in the hippocampus, ventral midbrain and cerebellum (Figures 1A & 1B). Notably, Sab 10 
expression parallels that of JNK isoforms (JNK1, JNK2, & JNK3), the only known binding 11 
partners for Sab in the brain (Carboni et al., 1998). In particular, JNK3, the predominant brain 12 
isoform, has its highest activity in the hippocampus of adult mouse brains (Brecht et al., 2005; 13 
Carboni et al., 1998; Lein et al., 2007). Given the interaction between JNK and Sab and their 14 
high expression, it is feasible to conceive that the JNK-Sab signaling nexus has a basic role in 15 
hippocampal physiology.  16 
The regions identified in Figures 1A and 1B support neuronal processes related to learning and 17 
memory as well as motor control. Furthermore, Figure 2 demonstrates that Sab is expressed in 18 
the synapses of neurons, which reinforces a putative role for this signaling nexus in 19 
neurotransmission, especially, when one considers that Sab is found in axon terminals and 20 
synapses (Figure 2B and 3D). Additionally, the identification of significant Sab levels in 21 
astrocytes may indicate an important role for mitochondrial JNK signaling in other cells within 22 
the brain. 23 
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Previous research related to Sab employed subcellular fractionation and fluorescent 1 
microscopy to determine that Sab is localized to mitochondria (Chambers et al., 2011a; Wiltshire 2 
et al., 2002; Win et al., 2011). For the first time, we used electron microscopy to determine the 3 
subcellular distribution of Sab. Gold particle labeling of Sab was found to be almost exclusively 4 
mitochondrial; intriguingly, Sab was not found to be associated with the ER (Figure 3B). This is 5 
interesting as mitochondria are intimately associated with the ER (Nunnari and Suomalainen, 6 
2012). The localization of Sab to mitochondria confirms the potential for this scaffold protein to 7 
sequester and concentrate MAPK signaling at mitochondria.  8 
Labeling of Sab was in mitochondria contained in dendritic profiles and axonal terminals 9 
(Figures 3B, 3C, and 3D). This is in agreement with the discovery of Sab in synaptosomes 10 
(Figures 2A & 2B). The presence of Sab in these subcellular compartments suggests that Sab 11 
may play a role in neurotransmission. The distribution of Sab in neurons may polarize the 12 
activities of JNK isoforms with similar distributions. JNK3, the prevailing isoform in the 13 
hippocampus, appears to be largely relegated to the nucleus; in contrast, JNK1 is found 14 
predominantly in the cell body cytoplasm, axons, and dendrites (Coffey et al., 2002; Lee et al., 15 
1999). This similar distribution of Sab and JNK1 may suggest a means by which JNK1 signaling 16 
could be enhanced on mitochondria through an interaction with Sab. However, we cannot 17 
currently rule out that Sab may interact with other JNK isoforms or MAPKs on neuronal 18 
mitochondria. 19 
At present, the precise function of Sab-mediated signaling in neurons is still unclear. One 20 
possibility is that Sab on the axonal mitochondria may be required for the expedited transport 21 
and recycling of depolarized mitochondria in an energetic demanding area like dendritic profiles 22 
and axonal terminals. Mitochondria are essential to synaptic transmission, as these organelle 23 
provide ATP and calcium (Ivannikov et al., 2013). MAPKs, specifically JNK, have been shown 24 
11 
 
to impact mitochondrial dynamics (Leboucher et al., 2012; Pyakurel et al., 2015). JNK has been 1 
shown to phosphorylate Mfn2 causing its degradation, which ultimately produced a fragmented 2 
mitochondrial network (Leboucher et al., 2012); likewise, ERK has been shown to act in the 3 
similar fashion with Mfn1 (Pyakurel et al., 2015). Sab could be the scaffold protein that 4 
facilitates these interactions. Thus, the Sab-MAPK interaction could be crucial to releasing 5 
mitochondria from the network in the cell body for use in axons and dendrites. One of the roles 6 
for JNK in the adult brain is in the transport of macromolecular complexes to and from the 7 
synapse via an interaction with molecular motor proteins (Horiuchi et al., 2007; Verhey et al., 8 
2001). One could also surmise that Sab is required to transport mitochondria to the synapse in a 9 
JNK-dependent manner. The roles of Sab-mediated signaling in axons and neurotransmission are 10 
under active investigation in our lab. 11 
Based on the expression and broad distribution of Sab in the brain and the 12 
complementary distribution of cytosolic JNK activity, we reasoned that Sab-mediated signaling 13 
may have a role in basic neurophysiology. Herein, we report that inhibition of Sab-mediated 14 
signaling by the Tat-SabKIM1 peptide significantly reduces the activity of cultured hippocampal 15 
neurons. In our electrophysiology experiments, inhibiting the Sab-JNK interaction caused a rapid 16 
reduction in neuronal activity. A similar effect has been noticed with JNK selective inhibitors in 17 
vitro and in vivo (Coffey, 2014; Yang et al., 2011). Wherein, small molecule JNK inhibitors 18 
induced a decrease in basal synaptic transmission. We propose that the effects of the Tat-SabKIM1 19 
peptide are compatible with diminished basal activity caused by a loss of mitochondrial JNK 20 
activity; however, we cannot preclude that the Tat-SabKIM1 peptide may be acting as a global 21 
JNK inhibitor (targeting both nuclear and mitochondrial signaling) in neurons. Alternatively, it is 22 
possible that impairing neuronal Sab-mediated signaling could impair mitochondrial function or 23 
induce dysfunction that would lead to an inability to support neuronal firing resulting in the 24 
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decreased spike rate and amplitude observed in our studies (Figure 4). Nonetheless, we suggest 1 
that Sab may be a novel platform for the regulation of synaptic transmission due to Sab’s 2 
distribution in the brain and neurons and its potential role in spontaneous activity. 3 
In this work, we have found that the mitochondrial MAPK scaffold protein Sab is well 4 
distributed throughout the adult brain. Sab is specifically enriched in the hippocampus, ventral 5 
midbrain, and cerebellum. Sab expression overlaps with that of JNK isoforms. Sab is present in 6 
neurons in the cell body, axons, and dendrites, and it is detected in synaptosomes suggesting that 7 
Sab-mediated signaling is present in synapses; furthermore, inhibition of Sab-mediated signaling 8 
impaired spontaneous firing of cultured hippocampal neurons. These data reinforce the 9 
importance of mitochondrial MAPK signaling in neurological function and disease. These 10 
studies represent a new perspective for MAPK signaling in the brain; wherein, regulation of 11 
subcellular MAPK signaling could be an essential factor in the balance of healthy cognitive 12 
function and neurodegenerative disease. 13 
4. Materials and Methods 14 
4.1 Ethical Standards and Animal Housing/Care: All experiments were approved by the 15 
institutional committees for animal care and utilization at Florida International University and 16 
the University of Torino; furthermore, studies were performed in accordance with the Society of 17 
Neuroscience and Italian guidelines. C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) 18 
were purchased at 4 weeks of age for studies conducted at FIU, while Sprague-Dawley rats 19 
(Harlan Laboratories, Indianapolis, IN) were purchased at 8 weeks of age. Mice were housed in 20 
sex-matched cages with no more than five (5) mice per cage, while rats were housed in pairs. 21 
Animals were allowed to feed ad libitum and were provided standard chow. 22 
4.2 Sample acquisition and brain dissection: Mice and rats were euthanized and the brains were 23 
removed as described in our previous work. For RT-PCR analyses, brains from six (6) animals 24 
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were sectioned into 0.5mm slices using a mouse brain matrix and frozen. For the microdissection 1 
of individual brain regions, specific slices were bilaterally punched with a 0.5mm diameter 2 
needle (Kasukawa et al., 2011). Two (2) slices were surveyed per animal for specific brain 3 
regions to assure replication within animals. For protein analysis, brains were dissected as 4 
previously described to isolate the olfactory bulb, frontal cortex, striatum, hippocampus, ventral 5 
midbrain, cerebellum, and brain stem (Spijker, 2011). For a ventral midbrain isolate that was 6 
devoid of hippocampus, cortex, cerebellum, and brain stem, we dissected the brain between -6.38 7 
and -2.6 bregma. The brain stem was considered the region between the ventral midbrain and 8 
spinal cord minus the cerebellum; this section specifically contained the pons and medulla. The 9 
dissected regions of the brains were then homogenized in T-PER (Thermo-Fisher Scientific) 10 
supplemented with protease and phosphatase inhibitors. Homogenates were then analyzed by 11 
western blot analysis as described below. Human fetal astrocytes were purchased from ScienCell 12 
Research Laboratories (Carlsbad California), and cultured according to manufacturer’s 13 
instructions. Astrocytes were lysed and analyzed by western blot analysis according to our 14 
previously published protocol (Chambers et al., 2011e; Chambers et al., 2013). 15 
4.3 RT-PCR detection of Sab:  RNA was isolated from tissue punches using the Trizol reagent, 16 
and cDNA was synthesized using Superscript II-mediated reverse transcription from 0.4g of 17 
total RNA. RT-PCR was performed in the ABI Prism 7500 instrument with SYBR Green 18 
reagents as previously described (Kasukawa et al., 2011).  To determine the Sab levels across 19 
specific brain regions, we used a probe specific for a 130bp stretch near the 5’-end of the Sab 20 
ORF (5’-CGGAGCCGAAATCCTGCCG-3’ and 5’-GACTGATTTAATTCTC-3’). RT-PCR 21 
results were normalized to both 18S rRNA and GAPDH levels in the brain. Data are presented in 22 
log2 format. 23 
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4.4 Primary hippocampal cultures: Mouse hippocampal neurons purchased from Gibco Life 1 
Technologies (A15587, Invitrogen, Carlsbad, CA) were plated in plastic 6-well plates, 2 
previously coated with 0.1 mg/mL of poly-L-lysine. The plating density was 1.6x105 cells/well. 3 
Neurons were grown for fourteen (14) days in Neurobasal medium supplemented with 2% B27 4 
and 0.5 mM L-glutamine, at 37°C and 5% CO2. 5 
4.5 Purification of synaptosomes: Synaptosomes were purified from Sprague Dawley rat brains 6 
(excluding the cerebellum) as previously described elsewhere (Sodero et al, 2012)(Pilo Boyl et 7 
al., 2007). Rats were used to provide a larger preparation of synaptosomes in the event 8 
mitochondria needed to be purified for western blot analysis. Briefly, the brains were quickly 9 
removed, the olfactory bulb and cerebellum were dissected out, and the tissue was homogenized 10 
in ice-cold buffer (320 mM sucrose, 1 mM EDTA and 5 mM HEPES; pH 7.4). The 11 
homogenization consisted of eight strokes in a glass-Teflon homogenizer.  The homogenate was 12 
spun at 3,000xg for 10 minutes. Then, the supernatant was spun at 14,000xg for 10 minutes. The 13 
pelleted crude synaptosomes were suspended in Kreb's-Ringer buffer (140 mM NaCl, 5 mM 14 
KCl, 5 mM glucose, 1 mM EDTA and 10 mM HEPES; pH 7.4) and mixed with Percoll to reach 15 
a final Percoll concentration of 45%. The samples were spun at 18,000xg for 2 minutes and the 16 
synaptosomes were recovered from the top of the Percoll suspension. Finally, the synaptosomes 17 
were washed in Kreb's-Ringer buffer by spinning them at 18000xg for 30 seconds. 18 
4.6 Lysis and Immunoblotting: Cultured neurons were washed 2 times with ice-cold PBS and 19 
then harvested in Radioimmunoprecipitation Assay (RIPA) buffer (50mM Tris-HCl, 150mM 20 
NaCl, 1% NP-40, 0.5% sodium deoxycholate and 0.1% sodium dodecyl sulfate, 5mM EDTA and 21 
1mM EGTA; pH 7.4) containing HALT® protease inhibitor and phosphatase inhibitor cocktails 22 
(Thermo Scientific, Waltham, MA). The lysate was cleared by centrifugation at 12,000 RPM for 23 
10 minutes. Purified synaptosomes and brain regions were also lysed in RIPA buffer. The protein 24 
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concentration of the different lysates was assessed in triplicates using the BCA Protein Assay 1 
(Pierce Biotechnology, Rockford, IL). Equivalent amounts of total protein were separated by 2 
SDS-PAGE and then transferred to nitrocellulose membranes.  The membranes were blocked 3 
with 3% BSA in TBS containing 0.1% (v/v) Tween-20 at room temperature for 1 hour, and then 4 
probed overnight with mouse monoclonal anti-Sab (1/1,000; Novus Biologicals #H00009467-5 
M01) and rabbit monoclonal anti GAPDH (1/1,000; Cell Signaling Technology #5174). The 6 
membranes were then incubated with appropriate fluorescent secondary antibodies (1/20,000; 7 
DyLight Anti-mouse 800 and Anti-rabbit 680, Cell Signaling Technologies, #5257 and #5366) 8 
for 1 hour at room temperature, and finally scanned using a Li-Cor Biosciences Odyssey CLx 9 
device. Images were quantified with the Image J 1.48v software (NIH, USA). 10 
4.7 Confocal microscopy: Anesthetized mice were perfused with Ringer’s solution followed by 11 
1% formaldehyde in 0.1 M phosphate buffer (PB). The brain was dissected and cut with a 12 
vibratome (100 m). Free-floating hippocampal sections were pre-incubated in 0.02 M PBS 13 
containing 5% normal goat serum (PBS–5% NGS) for 30 min, and then incubated overnight in 14 
mouse monoclonal anti-Sab diluted 1/500. Sections were then incubated for 1 hour in Alexa 15 
Fluor 488 anti-mouse IgG secondary antibodies (1/500), washed in PBS and mounted in 16 
Vectashield (Vector Laboratories) (Pilo Boyl et al., 2007). Routine immunocytochemical 17 
controls included the omission of the primary antibody. Images were acquired using a Zeiss 18 
Pascal confocal laser scanning microscope.  19 
4.8 Post-embedding electron microscopy: Hippocampal sections were obtained from tissue 20 
blocks that had been freeze-substituted with methanol and embedded in Lowicryl HM20 for a 21 
previous study (Pilo Boyl et al., 2007). Postembedding immunogold labeling was performed on 22 
ultrathin sections using goat anti-mouse secondary antibodies coupled to 10 nm colloidal gold 23 
particles (British BioCell International, Cardiff, UK). All procedures have been described in 24 
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detail in Sassoè-Pognetto and Ottersen (2000). The grids were observed with a JEM-1010 1 
transmission electron microscope (Jeol, Japan) equipped with a side-mounted CCD camera 2 
(Mega View III, Olympus Soft Imaging System, Germany). Gold labeling was quantified in 3 
randomly selected grid squares in CA1 stratum pyramidale (cell bodies) and stratum radiatum 4 
(dendrites and axon terminals) in sections from three mice (Sassoè-Pognetto and Ottersen, 2000). 5 
The area of profiles was measured using the Image J software. 6 
4.9 Electrophysiology: Whole-cell patch clamp recordings were performed on pairs of 7 
synaptically-linked cultured hippocampal neurons grown on coverslips for 14 days (Balena et al., 8 
2008; Hamill et al., 1981). The neurons were placed in artificial cerebrospinal fluid (ACSF – 9 
130mM NaCl, 2.5mM KCl, 15mM HEPES, 1.3mM NaH2PO4, 10mM glucose, 2mM CaCl2, and 10 
2mM MgSO4, pH 7.4) and adapted for 30 minutes. The cells were then transferred to a recording 11 
solution containing 145mM NaCl, 2.5mM KCl, 2mM CaCl2, 1mM MgCl2, and 10mM HEPES, 12 
pH 7.4. For high potassium experiments with concentration of KCl was increased to 25mM. The 13 
recording pipettes were pulled from glass capillaries with a resistance of 4-10M, and the 14 
pipette were filled with a solution of 135mM K-gluconate, 2mM MgCl2, 10mM HEPES, 7mM 15 
NaCl, and 2mM Na2ATP, pH 7.2 with an osmolarity of 270mOsm. Signals were recorded using 16 
an AxoPatch 200B amplifier with 2-kHz filter (Molecular Devices). Data were transferred from 17 
the pCLAMP 10 software (Molecular Devices) to GraphPad Prism 6.0 for analysis. 18 
To determine the effect of Sab-mediated signaling on spontaneous firing, primary hippocampal 19 
neurons adapting in ACSF were treated with either PBS, 5M Tat-SabKIM1 or the Tat-Scramble 20 
control for the final 15 minutes of acclimation. Neurons were then place in the extracellular 21 
solution mention above containing the same concentrations of peptide. To induce spontaneous 22 
firing, the potassium concentration in the solution was increased to 25mM. Signals were 23 
recorded for 30 seconds following the addition of potassium. 24 
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4.10 Statistical analysis and replicates:  Data were analyzed using one-sided analysis of variance 1 
(ANOVA) and Mann-Whitney tests. For all studies a minimum of three biological replicates or 2 
three animals were required. 3 
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 5 
8. Figure Legends 6 
Figure 1. Sab is differentially expressed in the adult rodent brain. RT-PCR was conducted to 7 
measure the expression levels of Sab in 49 areas of the adult mouse brain. Areas of increased Sab 8 
expression are marked as Hippocampus, VTA & SNpc, and Cerebellum (A). A representative 9 
western blot analysis of a dissected adult mouse brain showing the expression of Sab in different 10 
regions of the mouse brain (B). The relative Sab fluorescence was normalized to actin levels in 11 
each region. The average relative Sab expression from six (6) mice is presented for the western 12 
images and individual animal expression levels are illustrated as open circles on each column.  13 
(C).  14 
Figure 2. Sab is expressed in neurons, at synapses, and in astrocytes. Western blot analysis 15 
for Sab expression in primary hippocampal cultures was performed (A). Sab in rat synaptosomes 16 
was measured from four (4) adult rats (B). Sab levels were also monitored by western blot in 17 
human fetal astrocytes. COX-IV was used as a mitochondrial abundance control and GADPH 18 
was used as loading control. 19 
Figure 3. Sab localizes to mitochondria in hippocampal neurons. Sab immunoreactivity is 20 
concentrated in mitochondria. A. Confocal image through the hippocampal CA1. Immunolabeling for Sab 21 
is characterized by small puncta in the cell body and dendrites of hippocampal neurons. So: stratum 22 
oriens; Sp: stratum pyramidale; Sr: stratum radiatum. B. Electron micrograph showing immunogold 23 
labeling for Sab in the cell body of a pyramidal neuron. Gold particles decorate mitochondria (Mito), 24 
25 
 
whereas the nucleus (Nu), Golgi complex (Go) and endoplasmic reticulum (Er) are unlabeled. C. Strong 1 
mitochondrial labeling for Sab in a dendritic profile in stratum radiatum. D. Axo-spinous synapse in 2 
stratum radiatum; note the strong immunogold labeling for Sab in two mitochondria within the 3 
presynaptic axon terminal (Ax). Sp: dendritic spine. Scale bars: A = 10 mm; B = 250 nm (applies to B-D).  4 
Figure 4. Inhibition of Sab-mediated signaling decreases basal firing frequency and 5 
amplitude. Whole-cell patch clamp was performed on cultured hippocampal neurons that had 6 
been treated with either PBS (untreated), 5M Tat-Scramble, or 5M Tat-SabKIM1 for 15 minutes 7 
prior to high potassium treatment and recordings. Representative recordings for each treatment 8 
group are shown in (A). The spike frequency (B) and amplitude (C) was determined over 20 9 
seconds for each record for a minimum of four (4) cultures. Each experiment is represented with 10 
an open circle on each box and whisker plot (B & C). 11 
12 
26 
 
 1 
27 
 
 1 
28 
 
1 
29 
 
 1 
 2 
3 
30 
 
 1 
2 
31 
 
 1 
 2 
